Spain· ES:09545006
ONGLYZA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing saxagliptina, registered in Spain by Astrazeneca Ab.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- saxagliptina
- Manufacturer
- Astrazeneca Ab
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo70058628EUR 52.02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saxagliptina in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaONGLYZAAstraZeneca AB, Södertälje
- BelgiumOnglyza 5 mgAstraZeneca
- FranceONGLYZA 5 mg, comprimé pelliculéASTRAZENECA AB
- United StatesSaxagliptinAurobindo Pharma Limited
- NetherlandsOnglyza 5 mg, filmomhulde tablettenAstraZeneca AB
- IcelandOnglyzaAstraZeneca AB
- NorwayOnglyzaOrifarm AS
- PolandOnglyzaAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- France · Saxagliptine Arrow, Saxagliptine Biogaran
- United Kingdom (Northern Ireland) · Saxagliptin Sandoz, Saxagliptin Zydus Pharmaceuticals Uk
- Hungary · Saxagliptin Pharos
- Iceland · Onglyza
- Liechtenstein · Onglyza
- Malta · Saxagliptin Pharos
- Netherlands · Saxagliptine Sandoz
- Norway · Onglyza
- Portugal · Saxagliptina Generis, Saxagliptina Generis Phar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9aa7f41-485a-468e-a00c-0da2c15a2cfa GET /v1/drugs/c9aa7f41-485a-468e-a00c-0da2c15a2cfa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1258066800000}",
"nregistro": "09545006",
"substance": "saxagliptina"
}See everything about saxagliptina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.